Clinical trial · Interventional
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)
NCT05645146CI-TRIAL-00107036active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to help participants with a history of cervical cancer or high-grade cervical dysplasia quit smoking.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| High Grade Cervical Dysplasia | — | UNRESOLVED | — |
| Smoking Cessation | — | UNRESOLVED | — |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Motivation and Problem Solving (MAPS) intervention | Behavioral | — | UNRESOLVED |
| Nicotine Lozenge | Drug | — | UNRESOLVED |
| Nicotine patch | Drug | — | UNRESOLVED |
| Smoking Cessation treatment delivered by Tobacco Free Florida Quitline | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group 1: Standard Treatment
- description
- Participants will receive a connection to the Tobacco Free Florida Quitline and a 12 week supply of nicotine replacement therapy (the patch and lozenges)
- interventionNames
- Behavioral: Smoking Cessation treatment delivered by Tobacco Free Florida Quitline
- Drug: Nicotine patch
- Drug: Nicotine Lozenge
- type
- EXPERIMENTAL
- label
- Group 2: Motivation and Problem Solving (MAPS) counseling
- description
- Participants will receive a 12 week supply of nicotine replacement therapy (the patch and lozenges) along with the MAPS intervention, which consists of 6 MAPS counseling calls over 12 months, and individually tailored SMS text content driven by monthly smartphone delivered check-ins for 24 months
- interventionNames
- Drug: Nicotine patch
- Drug: Nicotine Lozenge
- Behavioral: Motivation and Problem Solving (MAPS) intervention
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * At least 100 cigarettes or more smoked in participants lifetime * Speaks English * Currently smoke 1 cigarette or more in the past 30 days * History of cervical cancer or high grade cervical dysplasia * Has a working smartphone * Has a valid home address * Reside in Florida at the time of study enrollment Exclusion Criteria: * Receiving behavioral or pharmacological tobacco treatment * Household member enrolled in this study
References
Publications (1)
- DERIVEDVidrine JI, Fennell BS, Simmons VN, Sutton SK, Jones SR, Woodward HW, Hoogland CE, Vidrine DJ. Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial. BMC Public Health. 2023 Jul 4;23(1):1284. doi: 10.1186/s12889-023-16189-3. PMID 37403057